PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsActinium Pharmaceuticals
Actinium Pharmaceuticals(ATNM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lintuzumab
myelomonocytic leukemia juvenile
,
multiple myeloma
,
plasma cell neoplasms
,
anemia
,
refractory anemia
,
glioblastoma
,
gliosarcoma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
myeloproliferative disorders
,
myelomonocytic leukemia chronic
,
promyelocytic leukemia acute
,
myelodysplastic-myeloproliferative diseases
,
refractory anemia with excess of blasts
,
bcr-abl positive chronic myelogenous leukemia
,
congenital abnormalities
,
leukemia myeloid chronic atypical bcr-abl negative
,
myeloid leukemia accelerated phase
,
blast crisis
,
neutropenia
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use